IL127033A - Method for early detection of lysosomal storage disorders and a kit for detecting the same - Google Patents

Method for early detection of lysosomal storage disorders and a kit for detecting the same

Info

Publication number
IL127033A
IL127033A IL12703397A IL12703397A IL127033A IL 127033 A IL127033 A IL 127033A IL 12703397 A IL12703397 A IL 12703397A IL 12703397 A IL12703397 A IL 12703397A IL 127033 A IL127033 A IL 127033A
Authority
IL
Israel
Prior art keywords
lysosomal storage
storage disorders
kit
detecting
same
Prior art date
Application number
IL12703397A
Other languages
English (en)
Other versions
IL127033A0 (en
Original Assignee
Women S And Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Women S And Childrens Hospital filed Critical Women S And Childrens Hospital
Publication of IL127033A0 publication Critical patent/IL127033A0/xx
Publication of IL127033A publication Critical patent/IL127033A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
IL12703397A 1996-05-17 1997-05-16 Method for early detection of lysosomal storage disorders and a kit for detecting the same IL127033A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN9917A AUPN991796A0 (en) 1996-05-17 1996-05-17 Early detection of lysosomal storage disorders
PCT/AU1997/000304 WO1997044668A1 (en) 1996-05-17 1997-05-16 Early detection of lysosomal storage disorders

Publications (2)

Publication Number Publication Date
IL127033A0 IL127033A0 (en) 1999-09-22
IL127033A true IL127033A (en) 2000-12-06

Family

ID=3794228

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12703397A IL127033A (en) 1996-05-17 1997-05-16 Method for early detection of lysosomal storage disorders and a kit for detecting the same

Country Status (10)

Country Link
US (2) US6759189B1 (enExample)
EP (1) EP1021725B1 (enExample)
JP (3) JP3837711B2 (enExample)
AT (1) ATE426169T1 (enExample)
AU (1) AUPN991796A0 (enExample)
CA (2) CA2253875C (enExample)
DE (1) DE69739317D1 (enExample)
IL (1) IL127033A (enExample)
NZ (1) NZ332641A (enExample)
WO (1) WO1997044668A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543425A (ja) * 1999-04-30 2002-12-17 ザ ナタン エス． クライン インスティテュート フォー サイキアトリック リサーチ アルツハイマー病の治療のための化合物の同定法
US7090987B1 (en) 1999-04-30 2006-08-15 Nixon Ralph A Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia
NZ543309A (en) 2003-03-31 2008-12-24 Womens & Childrens Hospital Multiplex screening for lysosomal storage disorders (LSDs)
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
ES2301280A1 (es) * 2005-05-16 2008-06-16 Fina Biotech S.L.U. Metodo para diagnosticar la enfermedad de alzheimer.
WO2007136782A2 (en) * 2006-05-19 2007-11-29 Historx, Inc. Kits and methods for evaluating misfolded proteins
EP2209890A4 (en) * 2006-12-13 2011-11-02 Tgr Biosciences Pty Ltd STIMULATION OF PRODUCTION OF EXTRACELLULAR MEDIA WITH FIBROBLAST CELLS AND / OR STIMULATION OF MIGRATION OF FIBROBLAST CELLS IN A BIOLOGICAL SYSTEM
EP2252325A4 (en) * 2008-03-12 2012-07-11 Amicus Therapeutics Inc TREATMENT OF MORBUS POMPE WITH SPECIFIC PHARMACOLOGICAL CHAPTERONES AND TREATMENT MONITORING WITH SURROGATE MARKERS
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
US9983200B2 (en) 2013-03-14 2018-05-29 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
US12020820B1 (en) 2017-03-03 2024-06-25 Cerner Innovation, Inc. Predicting sphingolipidoses (fabry's disease) and decision support
US11335461B1 (en) 2017-03-06 2022-05-17 Cerner Innovation, Inc. Predicting glycogen storage diseases (Pompe disease) and decision support
US11923048B1 (en) 2017-10-03 2024-03-05 Cerner Innovation, Inc. Determining mucopolysaccharidoses and decision support tool

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
AU2990692A (en) 1991-12-06 1993-06-10 Commonwealth Scientific And Industrial Research Organisation Diagnostic method for pompe's disease
CA2147887A1 (en) * 1992-10-30 1994-05-11 James W. Dennis Method for measuring glycosyltransferase activity

Also Published As

Publication number Publication date
CA2253875C (en) 2011-02-22
JP2001519894A (ja) 2001-10-23
JP2006061161A (ja) 2006-03-09
CA2253875A1 (en) 1997-11-27
JP2008289501A (ja) 2008-12-04
US6759189B1 (en) 2004-07-06
IL127033A0 (en) 1999-09-22
JP4260152B2 (ja) 2009-04-30
US20040191847A1 (en) 2004-09-30
WO1997044668A1 (en) 1997-11-27
EP1021725B1 (en) 2009-03-18
ATE426169T1 (de) 2009-04-15
EP1021725A1 (en) 2000-07-26
NZ332641A (en) 2000-05-26
CA2731490A1 (en) 1997-11-27
DE69739317D1 (de) 2009-04-30
JP3837711B2 (ja) 2006-10-25
EP1021725A4 (en) 2002-10-30
AUPN991796A0 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
IL127033A0 (en) A method for early detection of lysosomal storage disorders and a kit for detecting the same
WO2002079486A3 (fr) Milieux de detection specifique de staphylococcus aureus
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
ES2172750T3 (es) Microcapsulas sensibles al ph.
WO1999049807A3 (en) A device and method for performing a biological modification of a fluid
ATE316147T1 (de) Enzymsensor
CA2421007A1 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
WO2002040634A3 (en) Expression miniarrays and uses thereof
CA2229271A1 (en) Compositions containing hydroxy acids or retinoids
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
CA2213709A1 (en) Novel methods for diagnosing benign prostatic diseases
EP0630974A3 (en) Method and test kit for the detection of inorganic orthophosphate in the amplification of target nucleic acids.
WO2002014537A3 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
EP0924523A3 (de) Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen
CA2069611A1 (en) Method to Detect Bone and Other Connective Tissue Disorders in Humans and Animals
NZ334518A (en) Homocysteine desulphurase from the protozoan trichomonas vaginalis
WO2000034511A3 (de) Peptid screening test zum nachweis von ass
CA2339821A1 (en) Enzymatic measurement of mycophenolic acid
MY101096A (en) Compositions and methods for the detection of urease for the diagnosis of campylobacter pyloridis infection.
BG103098A (en) Colour composition including an agent contaning pyrogalols, salt of iron (ii) and organic acid
EP0433855A3 (en) N- and o-substituted aminophenol derivatives, intermediates for their preparation, their use as hydrolase substrates, a corresponding assay and diagnostic agents
NO974801L (no) Koldrengjöringspreparater basert på alkaner eller cykloalkaner og en organisk forbindelse omfattende en ketongruppe
BR0115689A (pt) Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
WO1999046401A3 (de) 14-3-3 proteine als sensitive biomarker für pollution u.a. mit pcbs und (xeno)östrogenen
BG104452A (en) New derivatives of the methylenebisphosphonic acid

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees